Wells Fargo & Company MN trimmed its holdings in shares of Monsanto Company (NYSE:MON) by 39.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 855,288 shares of the basic materials company’s stock after selling 547,957 shares during the period. Wells Fargo & Company MN owned about 0.19% of Monsanto worth $101,232,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the business. Puplava Financial Services Inc. lifted its position in Monsanto by 0.4% during the second quarter. Puplava Financial Services Inc. now owns 2,119 shares of the basic materials company’s stock valued at $251,000 after buying an additional 9 shares in the last quarter. Savant Capital LLC lifted its position in Monsanto by 0.4% during the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock valued at $349,000 after buying an additional 11 shares in the last quarter. Guardian Life Insurance Co. of America lifted its position in Monsanto by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock valued at $191,000 after buying an additional 11 shares in the last quarter. Enterprise Financial Services Corp lifted its position in Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares in the last quarter. Finally, Forward Management LLC lifted its position in Monsanto by 0.5% during the second quarter. Forward Management LLC now owns 3,201 shares of the basic materials company’s stock valued at $379,000 after buying an additional 16 shares in the last quarter. 74.79% of the stock is currently owned by hedge funds and other institutional investors.

In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at $6,522,654.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.

Shares of Monsanto Company (MON) opened at 118.27 on Friday. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $118.97. The firm’s 50-day moving average is $117.25 and its 200 day moving average is $116.44. The company has a market cap of $51.96 billion, a price-to-earnings ratio of 25.54 and a beta of 1.07.

Monsanto (NYSE:MON) last issued its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion during the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. Monsanto’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period last year, the business earned $2.17 earnings per share. Equities analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.83%. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.

MON has been the topic of a number of recent research reports. Zacks Investment Research raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Monday, September 4th. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Friday, September 1st. BidaskClub cut shares of Monsanto from a “hold” rating to a “sell” rating in a research report on Sunday, July 16th. Vetr raised shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research report on Wednesday, July 12th. Finally, Susquehanna Bancshares Inc reissued a “neutral” rating and set a $128.00 target price (up from $125.00) on shares of Monsanto in a research report on Tuesday, June 27th. Ten analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Monsanto currently has an average rating of “Hold” and a consensus price target of $124.09.

COPYRIGHT VIOLATION NOTICE: “Wells Fargo & Company MN Sells 547,957 Shares of Monsanto Company (MON)” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://www.thecerbatgem.com/2017/09/16/wells-fargo-company-mn-sells-547957-shares-of-monsanto-company-mon.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.